Form 4 for TWST Twist Bioscience Corp

Accepted 2024-11-06 00:00:00 ET · period of report 2024-11-04 · accession 0001214659-24-018501 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2024-11-06	2024-11-04	TWST	Cho Dennis	See Remarks	A - Grant	$0.00	+4,149	95.1K	+5%	$0
	2024-11-06	2024-11-04	TWST	Cho Dennis	See Remarks	S - Sale	$41.56	-659	94.5K	-0.7%	-$27.4K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-11-04	A	A	12,000	$0.00	87,289	D	—	—	(F1) Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.
2	Common	Common Stock	2024-11-04	A	D	7,851	$0.00	95,140	D	—	—	(F1) Represents performance stock units for which target criteria was determined to have been met on November 4, 2024. 60% of the PSUs remain subject to time-based vesting and will vest on October 1,2025, subject to continued service or acceleration of vesting as provided in the award agreement.
3	Common	Common Stock	2024-11-04	S	D	659	$41.56	94,481	D	—	—	(F2) Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.